πŸ‡ΊπŸ‡Έ FDA
Patent

US 7638333

Anthrax vaccine

granted A61KA61K2039/5256A61K2039/5258

Quick answer

US patent 7638333 (Anthrax vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/5256, A61K2039/5258, A61K2039/53